Overview


According to FutureWise analysis the market for albumin in 2023 is US$ 5.83 billion, and is expected to reach US$ 9.74 billion by 2031 at a CAGR of 6.60%.

Albumin is the most common type of protein in blood plasma, which helps maintain blood levels in arteries and veins and facilitates the transportation of hormones, enzymes, and vitamins throughout the body. The liver is responsible for its production, and once synthesized, albumin is quickly carried to the bloodstream. Healthy kidneys stop most of the albumin from entering the urine through filtration, resulting in minimal to no detectable albumin in the urine. However, if the kidneys are damaged, albumin can "leak" through their filters and into the urine. Lower levels of albumin in the blood indicate serious liver and kidney issues. High levels, known as hyperalbuminemia, can indicate conditions such as dehydration and diarrhea. The standard range for normal albumin levels is between 3.4 to 5.4 (g/dL) or 34 to 54 grams per liter (g/L).

There are three different types of albumin: human serum albumin (HSA), recombinant albumin, and bovine serum albumin (BSA). Human albumin, also known as Albuminex, is a packed globular protein with a molecular weight of 66.5 kilodaltons (kDa). It is composed of a single chain of 585 amino acids organized in three repeated homolog domains (sites I, II, and III). Each domain comprises two separate sub-domains (A and B). It has the highest demand among other biopharmaceutical solutions. Human albumin has interesting enzymatic properties, including esterase activity, enolase activity, effects on eicosanoids, aryl acylamidase activity, stereospecificity, and binding and activation of drug conjugates.

FutureWise Market Research has published a report that provides an insightful albumin market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, albumin market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Octapharma
  • Kedrion
  • CSL Behring
  • Shire (Baxter)
  • Grifols
  • Hualan Bio
  • Taibang Bio
  • RAAS
  • Greencross
  • Ventria Bioscience

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in 3D Printing Medical Device Market:

  • In April 2022, in the United States, Apotex Corp. launched Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxane.

  • In July 2021, Grifols signed a deal with ImmunoTek to open 21 plasma centers as part of its expansion strategy. This would help increase the market, sales, and innovation.

The increasing applications of albumin in emerging fields such as cell therapy, gene therapy, and protein-peptide formulation are expected to be a major driver for the albumin market over the forecast period. Albumin's unique properties make it essential in these advanced therapies, enhancing their stability, delivery, and effectiveness. As research and development continue to advance in these areas, the demand for albumin as a vital ingredient is expected to grow significantly, presenting a lucrative opportunity for the albumin market. Furthermore, increasing demand for blood and plasma products is expected to be a major element in modern medicine. It acts as a stabilizing agent, regulating blood levels and pressure and transporting vital substances like hormones, enzymes, and medications. Also, albumin's ability to support oncotic pressure is instrumental in surgeries and treatments for chronic conditions, ensuring that fluids and nutrients are efficiently distributed within the body. As such, the sustained demand for blood and plasma products is expected to boost the market growth of albumin. However, the occurrence of allergic reactions or adverse effects may impede the adoption of albumin in the market. These reactions may range from mild allergic responses to more severe hypersensitivity reactions, causing discomfort or, in rare cases, demanding medical intervention. The need for careful monitoring and the potential for adverse events may prevent some healthcare professionals from adopting albumin as a standard therapeutic intervention despite its proven benefits, further hindering the market growth.

By Product Type

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

By Application

  • Therapeutics
  • Drug Formulation
  • Vaccine
  • Component of Media
  • Other Applications

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the rise in life-threatening disorders such as liver and kidney diseases, the development of the healthcare sector, the high demand for albumin in R&D activities, the presence of key players, and the increase in funding and financial commitments in the field of life sciences by a large number of biopharmaceutical organizations and research institutes in the region is expected to boost the market for albumin throughout the forecast period. Moreover, the launch of new products, adoption of key initiatives such as partnerships, acquisitions, and rising investments are further expected to drive the market. For instance, in February 2022, Aadi Bioscience, Inc. launched FYARRO, a sirolimus protein-bound particle for injectable suspension designed for intravenous use to treat adult patients dealing with locally advanced unresectable or metastatic malignant PEComa. Therefore, the factors mentioned above are anticipated to drive market growth during the projection period in the area.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth
  • To provide with an exhaustive analysis on the Albumin Market By Product Type, By Application And By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and the Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Albumin Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Albumin Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Albumin Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Albumin Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Human Serum Albumin
        2. Bovine Serum Albumin
        3. Recombinant Albumin

  • 8.   Albumin Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Therapeutics
        2. Drug Formulation and Vaccine
        3. Component of Media
        4. Other Applications

  • 9.   North America Albumin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Albumin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Albumin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Albumin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Octapharma
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Kedrion
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CSL Behring
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Shire (Baxter)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Grifols
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Hualan Bio
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Hualan Bio
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. RAAS
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Greencross
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Ventria Bioscience
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients